L-Cysteine,compounds,mixt. with (2R)-3,4-dihydro-2,5,7,8-tetramethyl-2-[(4R,- 8R)-4,8,12-trimethyltridecyl]-2H-1- benzopyran-6-ol and 3,3'-diselenobis[alanine] (37226-05-4)
| Identification |
| Properties |
| Safety Data |
| |
 |
Other Product
- L-Methionine,compounds,mixt. with L-cysteine,L-cystine,(2R)-3,4-dihydro-2,5,7,8-tetramethyl- 2-[(4R,8R)-4,8,12-trimethyltridecyl]- 2H-1-benzopyran-6-yl acetate,N-[(2R)-2,4-dihydroxy-3,3-dimethyl-1- oxobutyl]-â-alanine calcium salt (2:1),(3aS,4S,6aR)-hexahydro-2-oxo-1H-thieno[3,- 4-d]imidazole-4-pentanoic acid,5-hydroxy-6-methyl-3,4-pyridinedimethanol,millet and riboflavin
- 2H-1-Benzopyran-6-ol,3,4-dihydro-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-, (2R)-,mixt. with hydroxysteroids (9CI)
- 2H-1-Benzopyran-6-ol,3,4-dihydro-2,5,7,8- tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-,acetate,(2R)-rel-,mixt. with lecithins
- L-Ascorbic acid,esters,6-hexadecanoate,mixt. with (2R)-3,4-dihydro-2,5,7,8-tetramethyl-2- [(4R,8R)-4,8,12-trimethyltridecyl]-2H-1- benzopyran-6-ol
- 2H-1-Benzopyran-6-ol,3,4-dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-,[2R-[2R*(4R*,8R*)]]-
- (2R-(2R*(4R*,8R*)))-3,4-Dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-2H-1-benzopyran-6-ol
- [2R-[2R*(4R*,8R*)]]-3,4-dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-2H-1-benzopyran-6-yl 5-oxo-L-prolinate
- Butanedioic acid,esters,mono[(2R)-3,4- dihydro-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,- 12-trimethyltridecyl]-2H-1-benzopyran-6-yl] ester,mixt. with selenious acid
- 3-Pyridinecarboxylicacid,(2R)-3,4-dihydro-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-2H-1-benzopyran-6-ylester, rel-
- 3-Pyridinecarboxylicacid,(2R)-3,4-dihydro-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-2H-1-benzopyran-6-ylester
- L-Ascorbic acid,6-hexadecanoate, mixt. withrel-(2R)-3,4-dihydro-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-2H-1-benzopyran-6-oland lecithins
- D-Gluconic acid,calcium salt (2:1),mixt. with rel-(2R)-3,4-dihydro-2,5,7,8-tetramethyl-2- [(4R,8R)-4,8,12-trimethyltridecyl]-2H-1- benzopyran-6-yl acetate,N-(1-methylethyl)-2-propanamine dichloroacetate and (17R)-19-norpregn-4-en-17-ol
- 2H-1-Benzopyran-6-ol,2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-, (2R)-
- 2H-1-Benzopyran-6-ol,2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-, acetate, (2R)-
- 2H-1-Benzopyran-6-ol,3,4-dihydro-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-,6-acetate, (2R)-rel-
- 2H-1-Benzopyran-6-ol,3,4-dihydro-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-,6-acetate, (2R)-
- 2H-1-Benzopyran-6-ol,3,4-dihydro-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-,dihydrogen phosphate, (2R)-
- 2H-1-Benzopyran-6-ol,3,4-dihydro-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-,dihydrogen phosphate, sodium salt, (2R)-
- Yohimban-16-carboxylic acid,17-hydroxy-,methyl ester,monohydrochloride,(16R,17R)-,mixt. with (2R)-3,4-dihydro-2,5,7,8-tetramethyl-2-[(4R,- 8R)-4,8,12-trimethyltridecyl]-2H-1- benzopyran-6-yl acetate,3-pyridinecarboxamide and Tribestan
- 2H-1-Benzopyran,3,4-dihydro-6-methoxy-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-,(2R)-
